Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vapocoolant versus subcutaneous lignocaine for pain of intravenous cannulation
ACTRN12608000414314Phase 4Completed
- Sponsor
- Austin Health
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine (2 arms), sponsored by Austin Health. Primary endpoint: Pain score of intravenous cannulation. Started Oct 2008; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on ACTRN12608000414314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000414314.